Sarah Johnson

8PUBLICATIONS
130CO-AUTHORS
Molecular targetsMedical bacteriologyInnate immunityGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 29, 2025
Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy.

Andreas G Hadjigeorgiou, Constantinos Harkos, Aditya K Mishra

|Jul 19, 2023
Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells.

Yogesh Goyal, Gianna T Busch, Maalavika Pillai

|Jun 01, 2023
Publisher Correction: Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.

Joon Seok Park, Francesca S Gazzaniga, Meng Wu

|May 03, 2023
Targeting PD-L2-RGMb overcomes microbiome-related immunotherapy resistance.

Joon Seok Park, Francesca S Gazzaniga, Meng Wu

|Jan 10, 2023
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Christopher P Vellano, Michael G White, Miles C Andrews

|Nov 11, 2022
Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration.

Yifan Zhou, Yusra B Medik, Bhakti Patel

Pageof 2

Frequent Collaborators

8 joint publications

Jennifer A Wargo

6 joint publications

Golnaz Morad

4 joint publications

Stephanie S Watowich

4 joint publications

Courtney W Hudgens